Journal
JOURNAL OF NATURAL PRODUCTS
Volume 72, Issue 12, Pages 2141-2144Publisher
AMER CHEMICAL SOC
DOI: 10.1021/np900499q
Keywords
-
Funding
- Ministry of Higher Education and Scientific Research, Egypt
- Triton Biopharma AG
- NIH [R01 A136596]
- USDA Agricultural Research Service Specific Cooperative Agreement [58-6408-2-0009]
- National Center for Research Resources [C06 RR-14503-01]
Ask authors/readers for more resources
One known and three new potent, selective, and nontoxic anti-MRSA metabolites, kaempferol 3-O-alpha-L-(2 '',3 ''-di-E-p-coumaroyl)rhamnoside (1) (IC50 2.0 mu g/mL), kaempferol 3-O-alpha-L-(2 ''-E-p-coumaroyl-3 ''-Z-p-coumaroyl)rhamnoside (2) (IC50 0.8 mu g/mL), kaempferol 3-O-alpha-L-(2 ''-Z-p-coumaroyl-3 ''-E-p-coumaroyl)rhamnoside (3) (IC50 0.7 mu g/mL), and kaempferol 3-O-alpha-L-(2 '',3 ''-di-Z-p-coumaroyl)rhamnoside (4) (IC50 0.4 mu g/mL), were isolated from the leaves of the common American sycamore, Platanus occidentalis. Compounds 2-4 are new. Due to the unusual selectivity, potency, and safety of the pure compounds and the semipure glycoside mixture against MRSA, it is clear that this represents a viable class of inhibitors to prevent growth of MRSA on surfaces and systemically.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available